Inventor · disambiguated record
Han Han
26 granted patents·10 pending applications·204 citations·filing 2013–2025
96Inventor score
Files withHERON THERAPEUTICS INC18CALIFORNIA INST OF TECHN6GUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD5BETTA PHARMACEUTICALS CO LTD2UNIV NEW YORK2
Top patents by PatentIndex Score
36 records- 0199US11173118B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·13 cites·18 claims
- 0298US11878074B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·7 cites·14 claims
- 0398US11744800B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·7 cites·30 claims
- 0498US10953018B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2019·Granted Mar 23, 2021·12 cites·18 claims
- 0598US10624850B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·12 cites·16 claims
- 0698US9974742B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2016·Granted May 22, 2018·18 cites·23 claims
- 0797US9974793B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·18 cites·22 claims
- 0897US9808465B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·23 cites·15 claims
- 0997US9561229B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2016·Granted Feb 7, 2017·22 cites·21 claims
- 1096US10500208B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·15 cites·17 claims
- 1196US9974794B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·14 cites·21 claims
- 1296US9132097B2Nanoparticles stabilized with nitrophenylboronic acid compositionsCALIFORNIA INST OF TECHN·Filed 2013·Granted Sep 15, 2015·17 cites·30 claims
- 1394US9468681B2Targeted nanoparticlesCALIFORNIA INST OF TECHN·Filed 2013·Granted Oct 18, 2016·10 cites·24 claims
- 1492US9446149B2Nanoparticles stabilized with nitrophenylboronic acid compositionsCALIFORNIA INST OF TECHN·Filed 2015·Granted Sep 20, 2016·5 cites·35 claims
- 1591US12290520B2Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·24 claims
- 1691US10166291B2Targeted nanoparticlesCALIFORNIA INST OF TECHN·Filed 2016·Granted Jan 1, 2019·3 cites·34 claims
- 1787US12115255B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 1887US11650171B2Offcut angle determination using electron channeling patternsFEI CO·Filed 2021·Granted May 16, 2023·2 cites·19 claims
- 1986US12115254B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2084US2025228867A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2184US2024238197A1Methods of use of emulsion formulations of an nk-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2282US11234550B2Squeezing threaded rod, squeezing component, and food processorGUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD·Filed 2018·Granted Feb 1, 2022·3 cites·11 claims
- 2382US11096513B2Drive assembly and food processorGUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD·Filed 2018·Granted Aug 24, 2021·3 cites·11 claims
- 2477US2021186981A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2573US2021283258A1Targeted nanoparticlesCALIFORNIA INST OF TECHN·Filed 2021·Application pending·0 cites
- 2672US12336988B2Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-RAS signaling inhibitionUNIV NEW YORK·Filed 2022·Granted Jun 24, 2025·0 cites·3 claims
- 2766US2025332163A1Therapeutic targeting of kmt2d mutant lung squamous cell carcinoma through rtk-ras signaling inhibitionUNIV NEW YORK·Filed 2025·Application pending·0 cites
- 2865US11285212B2Targeted nanoparticlesCALIFORNIA INST OF TECHN·Filed 2018·Granted Mar 29, 2022·0 cites·23 claims
- 2962US2025316533A1Conductive path with reduced resistanceTAIWAN SEMICONDUCTOR MFG CO LTD·Filed 2024·Application pending·0 cites
- 3055US11717104B2Spiral blade, grinding component and food processorGUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·12 claims
- 3155US11446890B2Food processorGUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·19 claims
- 3255US2023321100A1Cd73 inhibitor and application thereof in medicineBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3354US11717798B2Food processorGUANGDONG MIDEA CONSUMER ELECTRIC MFG CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·21 claims
- 3453US2016324798A1Polymer-based compositions for extended release of proteinsHERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3552US2024282644A1Deviation measurement deviceACM RESEARCH SHANGHAI INC·Filed 2022·Application pending·0 cites
- 3652US2023339882A1Shp2 inhibitor and composition and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Han Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →